QGEN - QIAGEN N.V.
46.88
-0.770 -1.642%
Share volume: 1,975,041
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$47.65
-0.77
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | |
|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | |
| Report Date | 05-01-2024 | 08-02-2024 | |
| Total revenue | 458.796 M | 496.347 M | |
| Cost of revenue | 151.734 M | 446.371 M | |
| Gross profit | 307.062 M | 49.976 M | |
| -83.72% | |||
| Operating expenses | 190.022 M | 192.407 M | |
| Selling general and admin | 138.689 M | 143.304 M | |
| Research and development | 51.333 M | 49.103 M | |
| Total expenses | 360.551 M | 656.704 M | |
| 82.14% | |||
| Operating income | 98.245 M | -160.357 M | |
| Ebit | 98.245 M | -160.357 M | |
| Pretax income | 102.290 M | -223.451 M | |
| -318.45% | |||
| Income tax | 21.617 M | -39.991 M | |
| Net income basic | 80.673 M | -183.460 M | |
| -327.41% | |||
| Net income | 80.673 M | -183.460 M | |
| -327.41% |